Michael Scolaro

Michael Scolaro

Oct 16, 2017

Group 6 Copy 189
1
Please wait...

About This Project

We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

Blast off!

Browse Other Projects on Experiment

Related Projects

A randomized and controlled trial to examine the impact of lingual frenotomy on bottle feeding mechanics

Some babies are born with tongue-tie where an unusually short or tight band of tissue tethers the bottom...

Dicty World Race - finding the fastest and smartest Dicty cells

On May 16, Dicty and HL60 cells will race for the "fastest &smartest" title. Both cell types are models...

What is the role of copper and zinc dyshomeostasis in Alzheimer's disease pathology?

Alzheimer's Disease, the 6th leading cause of US deaths, is characterized by amyloid-beta(Aβ) plaques and...

Backer Badge Funded